Only one PRKDC polymorphism, intron 8 G6721T (SNP rs7003908), has been identified to be associated with a significant increase risk in carcinogenesis (glioma, bladder, colorectal, and prostate cancer) [128,129,130,131]. This evidence concerns the gene PRKDC and prostate cancer.